Sun Pharmaceutical Industries acquires Ranbaxy Laboratories $3.2 billion

Sun Pharmaceutical acquires Ranbaxy for $3.2 billion

6:22 AM, 7th April 2014
Sun Pharmaceutical Industries business acquisition news

MUMBAI/ GURGAON, INDIA: Sun Pharmaceutical Industries Ltd will buy Ranbaxy Laboratories Ltd in a $3.2 billion all-share deal. Ranbaxy, India’s biggest drugmaker by sales and 63.4 per cent owned by Japan’s Daiichi Sankyo Co Ltd, is banned from exporting drug ingredients to the US Sun Pharmaceutical’s Karkhadi plant (Gujarat, India), it is also barred from shipping products by the US Food and Drug Administration.

Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own. Daiichi Sankyo said in a statement that it will hold a stake of about 9 per cent in Sun Pharmaceutical after the deal.

India’s pharmaceutical industry, which supplies more than 20 per cent of the world’s generic drugs, according to PricewaterhouseCoopers, suffers from a lack of oversight including a severe shortage of regulatory inspectors. Daiichi has dispatched personnel and promised to provide the necessary support to resolve lingering quality problems at Ranbaxy, in which it first invested in 2008.


© Reuters News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Medical device inside the body to dissolve completely when triggered

AMES, US: A medical device can harmlessly melt away inside a person’s body, once its job is done. Or, a military device could collect and send i ...

Read more
Massive fire at chemical factory in Valsad, India

VALSAD, INDIA: A massive fire caught at chemical factory at Valsad, Gujarat, India causing damaging to the entire goods. Property worth millions were ...

Read more
BASF, Aquasource entre strategic cooperation

LUDWIGSHAFEN, GERMANY: inge GmbH, a subsidiary of BASF SE and a world’s leading supplier of ultrafiltration (UF) membranes and Aquasource, a lea ...

Read more
China’s Hubei launches carbon market to reduce greenhouse gas emission

WUHAN/BEIJING, CHINA: China’s Hubei province launched its carbon market on 2 April 2014, imposing caps on greenhouse gas emissions from 140 majo ...

Read more
BASF, Amyris collaborate for research and development

EMERYVILLE, US/LUDWIGSHAFEN, GERMANY: Amyris is entering a collaborative research and development agreement with BASF SE. Amyris will use its strain e ...

Read more
Chevron Phillips to build petrochemical facility in Texas, US

THE WOODLANDS, US: Chevron Phillips Chemical Company LP broke grounds at the Cedar Bayou plant in Baytown, Texas for US Gulf Coast (USGC) Petrochemica ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X